wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q30679247-96119676-E4AB-4042-96A7-C0B982A60542
Q30679247-96119676-E4AB-4042-96A7-C0B982A60542
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30679247-96119676-E4AB-4042-96A7-C0B982A60542
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.
P2860
Q30679247-96119676-E4AB-4042-96A7-C0B982A60542
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30679247-96119676-E4AB-4042-96A7-C0B982A60542
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbbfa75f9d517f8cbc5e2695d3972e9af771d5bd
P2860
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease.